Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population

Digestive and Liver Disease

Volumn 40, Issue 9, 2008, Pages 723-730

  Ferguson, L R ^a,f   Browning, B L ^a,f   Huebner, C ^a,f   Petermann, I ^a,f   Shelling, A N ^a,f   Demmers, P ^b,f   McCulloch, A ^c,f   Gearry, R B ^d,e   Barclay, M L ^e   Philpott, M ^a,f  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^c INVERMAY AGRICULTURAL CENTRE   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e CHRISTCHURCH HOSPITAL   (New Zealand)

^f Nutrigenomics New Zealand   (New Zealand)

Author keywords

Crohn's disease; Defensins; Inflammatory bowel disease; Single nucleotide polymorphism; Ulcerative colitis

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 5; AZATHIOPRINE; DNA; MERCAPTOPURINE; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHILD; COHORT ANALYSIS; COLITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HIGH RISK POPULATION; HUMAN; INFANT; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADULT; ALPHA-DEFENSINS; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEW ZEALAND; ODDS RATIO; PANETH CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY;

EID: 48149105842     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.02.011     Document Type: Article

References (41)

1. Szyk A., Wu Z., Tucker K., Yang D., Lu W., and Lubkowski J. Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci 15 (2006) 2749-2760
2. Ayabe T., Ashida T., Kohgo Y., and Kono T. The role of Paneth cells and their antimicrobial peptides in innate host defense. Trends Microbiol 12 (2004) 394-398
3. Ouellette A.J. Paneth cell alpha-defensin synthesis and function. Curr Top Microbiol Immunol 306 (2006) 1-25
4. Orholm M., Munkholm P., Langholz E., Nielsen O.H., Sorensen T.I., and Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 324 (1991) 84-88
5. Meucci G., Vecchi M., Torgano G., Arrigoni M., Prada A., Rocca F., et al. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology 103 (1992) 514-519
6. Probert C.S., Jayanthi V., Hughes A.O., Thompson J.R., Wicks A.C., and Mayberry J.F. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 34 (1993) 1547-1551
7. Orholm M., Binder V., Sorensen T.I., Rasmussen L.P., and Kyvik K.O. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 35 (2000) 1075-1081
8. Mathew C.G., and Lewis C.M. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 13 (2004) R161-R168
9. van Heel D.A., Fisher S.A., Kirby A., Daly M.J., Rioux J.D., and Lewis C.M. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 13 (2004) 763-770
10. Wehkamp J., and Stange E.F. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann NY Acad Sci 1072 (2006) 321-331
11. Porter E.M., van Dam E., Valore E.V., and Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 65 (1997) 2396-2401
12. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., and Bevins C.L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422 (2003) 522-526
13. Hazrati E., Galen B., Lu W., Wang W., Ouyang Y., Keller M.J., et al. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 177 (2006) 8658-8666
14. Buck C.B., Day P.M., Thompson C.D., Lubkowski J., Lu W., Lowy D.R., et al. Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci USA 103 (2006) 1516-1521
15. Gearry R.B., Richardson A., Frampton C.M., Collett J.A., Burt M.J., Chapman B.A., et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 12 (2006) 936-943
16. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170 (1989) 2-6 [discussion 16-9]
17. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
18. Burt M.J., George P.M., Upton J.D., Collett J.A., Frampton C.M., Chapman T.M., et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43 (1998) 830-836
19. Hattersley A.T., and McCarthy M.I. What makes a good genetic association study?. Lancet 366 (2005) 1315-1323
20. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
21. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
22. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., and Altshuler D. Efficiency and power in genetic association studies. Nat Genet 37 (2005) 1217-1223
23. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., and Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74 (2004) 106-120
24. Leushner J., and Chiu N.H. Automated mass spectrometry: a revolutionary technology for clinical diagnostics. Mol Diagn 5 (2000) 341-348
25. Sasieni P.D. From genotypes to genes: doubling the sample size. Biometrics 53 (1997) 1253-1261
26. Wigginton J.E., Cutler D.J., and Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76 (2005) 887-893
27. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
28. Lewontin R.C. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49 (1964) 49-67
29. Fahlgren A., Hammarstrom S., Danielsson A., and Hammarstrom M.L. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol 131 (2003) 90-101
30. Cunliffe R.N. Alpha-defensins in the gastrointestinal tract. Mol Immunol 40 (2003) 463-467
31. Lawrance I.C., Fiocchi C., and Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10 (2001) 445-456
32. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 102 (2005) 18129-18134
33. Kiehne K., Brunke G., Wegner F., Banasiewicz T., Folsch U.R., and Herzig K.H. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 12 (2006) 1056-1062
34. Liu L., Zhao C., Heng H.H., and Ganz T. The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 43 (1997) 316-320
35. Ghosh D., Porter E., Shen B., Lee S.K., Wilk D., Drazba J., et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 3 (2002) 583-590
36. de Leeuw E., Burks S.R., Li X., Kao J.P., and Lu W. Structure-dependent functional properties of human defensin 5. FEBS Lett 581 (2007) 515-520
37. Cordell H.J., and Clayton D.G. Genetic association studies. Lancet 366 (2005) 1121-1131
38. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M., Ambudkar S.V., et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315 (2007) 525-528
39. Fellermann K., Stange D.E., Schaeffeler E., Schmalzl H., Wehkamp J., Bevins C.L., et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79 (2006) 439-448
40. Linzmeier R.M., and Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics 86 (2005) 423-430
41. Zhang C., Yadava P., Sun J., and Hughes J.A. A gene delivery approach for antimicrobials: expression of defensins. J Drug Target 14 (2006) 646-651